Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06347393Not ApplicableActive Not Recruiting

Transgender and Gender Diverse Individuals Screening for Breast Cancer

Role: collaborator

NCT06852183Not ApplicableNot Yet Recruiting

Restructuring Body Experience in Anorexia Nervosa: Virtual Reality Functionality-Focused Mirror Exposure

Role: collaborator

NCT05925790Recruiting

Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels

Role: collaborator

NCT05081115Recruiting

Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging

Role: lead

NCT03049995Unknown

Stress Echo 2020 - The International Stress Echo Study

Role: lead

NCT04327323Unknown

CCM Italian Registry

Role: collaborator

All 6 trials loaded